Revoche e sospensioni, ritiri di lotti, farmaci carenti, note di sicurezza, rimborsabilità e nuovi medicinali — ogni giorno, automaticamente. Ultimo aggiornamento: 17/11/2026 08:15.
n. EU/1/10/642 · autorizzato il 17/09/2010 · Ibandronic Acid Teva is indicated in adults for the prevention of skeletal events (pathological fractures, bon… · Teva B.V. · Ibandronic acid · ATC M05BA06
Problemi produttivi · equivalente: Sì · 500 mg/10 ml polvere e solvente per concentrato per soluzione per infusione> 1 flaconcino di vetro con polvere + 1 fiala di vetro con solvente 10 ml · AIC 027529039 · MALESCI ISTITUTO FARMACOBIOLOGICO S.P.A. · CLARITROMICINA LATTOBIONATO · ATC J01FA09
n. EU/1/26/2060 · Nezglyal is indicated for the treatment of Cerebral Adrenoleukodystrophy (cALD) in males with Adrenoleukodystr… · Minoryx Therapeutics S.L. · leriglitazone · ATC A16AX23
n. EU/1/20/1437 · autorizzato il 31/07/2020 · Dovprela is indicated in combination with bedaquiline, linezolid and moxifloxacin for the treatment of
adul… · Viatris Healthcare Limited · pretomanid · ATC J04AK08
n. EU/1/17/1175 · autorizzato il 22/03/2017 · Daptomycin is indicated for the treatment of the following infections (see sections 4.4 and 5.1).
- Adult an… · Pfizer Europe MA EEIG · daptomycin · ATC J01XX09
n. EU/1/21/1615 · autorizzato il 13/04/2022 · <u>Muscle invasive bladder cancer (MIBC)</u>
Padcev, in combination with pembrolizumab, as neoadjuvant trea… · Astellas Pharma Europe B.V. · enfortumab vedotin · ATC L01FX13
n. EU/1/24/1833 · autorizzato il 25/07/2024 · Cejemly in combination with platinum-based chemotherapy is indicated for the first line treatment of adults wi… · CStone Pharmaceuticals Ireland Limited · sugemalimab · ATC L01FF11
n. EU/1/21/1608 · autorizzato il 06/01/2022 · Adults
Wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for wei… · Novo Nordisk A/S · semaglutide · ATC A10BJ06
n. EU/1/23/1770 · autorizzato il 07/12/2023 · ELREXFIO is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple… · Pfizer Europe MA EEIG · elranatamab · ATC L01FX32
n. EU/1/09/594 · autorizzato il 30/11/2009 · Hirobriz Breezhaler is indicated for maintenance bronchodilator treatment of airflow obstruction in adult pati… · Novartis Europharm Limited · indacaterol · ATC R03AC18
n. EU/1/09/586 · autorizzato il 30/11/2009 · Oslif Breezhaler is indicated for maintenance bronchodilator treatment of airflow obstruction in adult patient… · Novartis Europharm Limited · indacaterol · ATC R03AC18
n. EU/1/09/586 · autorizzato il 30/11/2009 · Oslif Breezhaler is indicated for maintenance bronchodilator treatment of airflow obstruction in adult patient… · Novartis Europharm Limited · indacaterol · ATC R03AC18
n. EU/1/26/2063 · ICOTYDE is indicated for the treatment of moderate to severe plaque psoriasis in adults, and adolescents 12 ye… · Janssen-Cilag International N.V. · icotrokinra hydrochloride
n. EU/1/26/2058 · Susvimo is indicated in adult patients for the treatment of neovascular (wet) age related macular degeneration… · Roche Registration GmbH · ranibizumab · ATC S01LA04
n. EU/1/09/594 · autorizzato il 30/11/2009 · Hirobriz Breezhaler is indicated for maintenance bronchodilator treatment of airflow obstruction in adult pati… · Novartis Europharm Limited · indacaterol · ATC R03AC18
n. EU/1/09/586 · autorizzato il 30/11/2009 · Oslif Breezhaler is indicated for maintenance bronchodilator treatment of airflow obstruction in adult patient… · Novartis Europharm Limited · indacaterol · ATC R03AC18
n. EU/1/09/586 · autorizzato il 30/11/2009 · Oslif Breezhaler is indicated for maintenance bronchodilator treatment of airflow obstruction in adult patient… · Novartis Europharm Limited · indacaterol · ATC R03AC18
n. EU/1/26/2063 · ICOTYDE is indicated for the treatment of moderate to severe plaque psoriasis in adults, and adolescents 12 ye… · Janssen-Cilag International N.V. · icotrokinra hydrochloride
n. EU/1/26/2058 · Susvimo is indicated in adult patients for the treatment of neovascular (wet) age related macular degeneration… · Roche Registration GmbH · ranibizumab · ATC S01LA04
n. EU/1/09/594 · autorizzato il 30/11/2009 · Hirobriz Breezhaler is indicated for maintenance bronchodilator treatment of airflow obstruction in adult pati… · Novartis Europharm Limited · indacaterol · ATC R03AC18
n. EU/1/09/586 · autorizzato il 30/11/2009 · Oslif Breezhaler is indicated for maintenance bronchodilator treatment of airflow obstruction in adult patient… · Novartis Europharm Limited · indacaterol · ATC R03AC18
n. EU/1/09/586 · autorizzato il 30/11/2009 · Oslif Breezhaler is indicated for maintenance bronchodilator treatment of airflow obstruction in adult patient… · Novartis Europharm Limited · indacaterol · ATC R03AC18
n. EU/1/26/2063 · ICOTYDE is indicated for the treatment of moderate to severe plaque psoriasis in adults, and adolescents 12 ye… · Janssen-Cilag International N.V. · icotrokinra hydrochloride
n. EU/1/26/2058 · Susvimo is indicated in adult patients for the treatment of neovascular (wet) age related macular degeneration… · Roche Registration GmbH · ranibizumab · ATC S01LA04
n. EU/1/09/594 · autorizzato il 30/11/2009 · Hirobriz Breezhaler is indicated for maintenance bronchodilator treatment of airflow obstruction in adult pati… · Novartis Europharm Limited · indacaterol · ATC R03AC18
n. EU/1/09/586 · autorizzato il 30/11/2009 · Oslif Breezhaler is indicated for maintenance bronchodilator treatment of airflow obstruction in adult patient… · Novartis Europharm Limited · indacaterol · ATC R03AC18
n. EU/1/09/586 · autorizzato il 30/11/2009 · Oslif Breezhaler is indicated for maintenance bronchodilator treatment of airflow obstruction in adult patient… · Novartis Europharm Limited · indacaterol · ATC R03AC18
n. EU/1/26/2063 · ICOTYDE is indicated for the treatment of moderate to severe plaque psoriasis in adults, and adolescents 12 ye… · Janssen-Cilag International N.V. · icotrokinra hydrochloride
n. EU/1/26/2058 · Susvimo is indicated in adult patients for the treatment of neovascular (wet) age related macular degeneration… · Roche Registration GmbH · ranibizumab · ATC S01LA04
n. EU/1/09/594 · autorizzato il 30/11/2009 · Hirobriz Breezhaler is indicated for maintenance bronchodilator treatment of airflow obstruction in adult pati… · Novartis Europharm Limited · indacaterol · ATC R03AC18
n. EU/1/09/586 · autorizzato il 30/11/2009 · Oslif Breezhaler is indicated for maintenance bronchodilator treatment of airflow obstruction in adult patient… · Novartis Europharm Limited · indacaterol · ATC R03AC18
n. EU/1/09/586 · autorizzato il 30/11/2009 · Oslif Breezhaler is indicated for maintenance bronchodilator treatment of airflow obstruction in adult patient… · Novartis Europharm Limited · indacaterol · ATC R03AC18
n. EU/1/26/2063 · ICOTYDE is indicated for the treatment of moderate to severe plaque psoriasis in adults, and adolescents 12 ye… · Janssen-Cilag International N.V. · icotrokinra hydrochloride
n. EU/1/26/2058 · Susvimo is indicated in adult patients for the treatment of neovascular (wet) age related macular degeneration… · Roche Registration GmbH · ranibizumab · ATC S01LA04
fine presunta 31/10/2026 · Problemi produttivi · equivalente: Sì · 500 MG COMPRESSE RIVESTITE CON FILM - 5 COMPRESSE IN BLISTER PVC/PVDC/AL · AIC 039686136 · TEVA ITALIA S.R.L. · LEVOFLOXACINA · ATC J01MA12
n. EU/1/24/1867 · autorizzato il 14/11/2024 · Afqlir is indicated for adults for the treatment of
• neovascular (wet) age-related macular degeneration (AM… · Sandoz GmbH · aflibercept · ATC S01LA05